STEMI (ST elevation myocardial infarction), Left ventricular thrombosis research hub

Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI: an open label randomized controlled multicenter Phase-II study

This study looks at new medicines to dissolve blood clots in the heart after a heart attack. It compares a new drug called dabigatran with a standard one, warfarin-like medicines, to see which works best and is safest for preventing further clots and strokes.